Otero Jose Manuel

Chief Operating Officer

Otero Jose Manuel has filed 9 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.

On the most recent filing, Otero Jose Manuel is listed as Chief Operating Officer at Lexeo Therapeutics, Inc. Inside the rolling window, Otero Jose Manuel reported no open-market purchases and 7 open-market sales totaling $86K in LXEO. The largest disclosed transaction in the window is a sale of 4,666 LXEO shares on Jul 1, 2026, worth $21K.

Companies traded

Other insiders at LXEO

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$86K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LXEOSale$6KAug 19SEC ↗
LXEOSale$21KJul 1SEC ↗
LXEOSale$7KMay 20SEC ↗
LXEOSale$7KFeb 20SEC ↗
LXEOSale$19KFeb 20SEC ↗
LXEOSale$7KNov 20SEC ↗
LXEOSale$19KOct 17SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Otero Jose Manuel made?

Otero Jose Manuel has filed 9 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.

Which companies does Otero Jose Manuel trade?

Otero Jose Manuel has filed SEC Form 4 disclosures for 1 company, including LXEO.

When was Otero Jose Manuel's most recent SEC Form 4 filing?

Otero Jose Manuel's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.

What is Otero Jose Manuel's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Otero Jose Manuel is listed as Chief Operating Officer.

What is Otero Jose Manuel's total buy and sell value in the current window?

Inside the rolling retention window, Otero Jose Manuel bought $0 and sold $86K based on SEC Form 4 filings.

What was Otero Jose Manuel's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 4,666 LXEO shares on 2026-07-01, worth $21K, per SEC Form 4 filings.